• Home
  • Articles
  • COVID-19
  • News
    • Biotech News – Featured
    • Biotech News
    • BioGadgets
  • Interviews
    • Interviews – Academia
    • Interviews – Industry
  • Issues
  • Subscribe
  • Board
  • Advertise
Facebook Twitter Instagram
Trending
  • Govt funds dry up to honour Indian scientists
  • Elsevier ranked Prof Ashok Pandey among top 5 scientists of India
  • A tribute to Father of Indian Green Revolution Dr M S Swaminathan
  • The Lancet was made for political activism- For 200 years, it has thrived on melodrama and scandal
  • Valo Therapeutics Announces Acquisition of Bruker Corporation’s Latest Mass Spectrometer Platform for Tumor Antigen Identification with ValoTx’s PeptiCHIP Technology
  • FABA and ABF Conduct Hands-on Training on CRISPR-Cas-Mediated Genome Editing in Plants
  • US FDA grants Orphan Drug Designation for CRO-67
  • Integrative Medicines (IM) Market to Grow with a High CAGR during 2023-2035; Increasing Adoption of Natural Remedies Around the World to Drive Market Growth
Biotech Express Magazine
  • Home
  • Articles
  • COVID-19
  • News
    • Biotech News – Featured
    • Biotech News
    • BioGadgets
  • Interviews
    1. Interviews – Academia
    2. Interviews – Industry
    Featured
    January 16, 20211

    Interview – Prof Rajeev K Varshney “The Youngest Indian Scientist (47)” who achieved an h-index of 100 recently

    Recent
    May 22, 2023

    Prof Rajeev Varshney becomes the 4th Indian Agricultural Scientist to be elected as Fellow of the Royal Society

    July 26, 2022

    We are making best hygiene solutions through Biotech applications: Dr Rachna Dave, founder MicroGO

    March 30, 2022

    Interview- Bioenergy: India’s Ministry of New and Renewable Energy started almost four decades ago…but did not catch up…, Professor Ashok Pandey

  • Issues
  • Subscribe
  • Board
  • Advertise
Biotech Express Magazine
You are at:Home»BioControversial»JNU Prof Files Defamation Suit Against Journalists, Seeks Rs 50 Lakh in Damages

JNU Prof Files Defamation Suit Against Journalists, Seeks Rs 50 Lakh in Damages

0
By Biotech Express on September 18, 2021 BioControversial, Biotech News

This article was originally written on online platform the wire and appeared on September 18, 2021.

On August 4, 2021, Mohana Basu of The Print reported that almost a dozen papers coauthored by a scientist at the Jawaharlal Nehru University, New Delhi, who was also an assembly poll candidate for the Bharatiya Janata Party in the West Bengal assembly polls earlier this year, had been flagged for potential manipulation.

The affidavit names Gobardhan Das as the plaintiff and Shekhar Gupta, Mohana Basu, Priyanka Pulla, Saba Naqvi and Twitter, Inc. as defendants.

Eleven papers coauthored by Gobardhan Das, a professor of molecular medicine, have been flagged on the independent peer-review platform PubPeer over the last two months. Basu had written in her report: “Das … is the corresponding or main author of eight of these papers and a co-author for the rest. Ved Prakash Dwivedi, a researcher at the Delhi-based International Centre for Genetic Engineering and Biotechnology, is a co-author of five of the 11 papers. Anand Ranganathan, a professor at the same JNU centre” – the Special Centre for Molecular Medicine – is a co-author of three of the 11 papers, among others.”

Basu reported for The Print that Das believed that he was being targeted on PubPeer for his political affiliation, and quoted Dwivedi saying that the issued raised on the platform were being dealt with there itself. But since Basu’s article was published, she has been named in a lawsuit by Das alleging (civil) defamation, along with The Print‘s editor Shekhar Gupta, independent journalists Priyanka Pulla and Saba Naqvi, and the Twitter company.

Both Pulla and Naqvi have been named because they published tweets about Basu’s report and the reviewers’ comments published in PubPeer.

The civil suit, a copy of which The Wire Science has seen, has been filed at the Patiala house court, New Delhi, and is dated August 31, 2021. It says that Das believes he “is at the receiving end of a conspiracy to discredit him and his work at the behest of certain envious co-professionals”.

Through the suit, Das is seeking Rs 50 lakh as “damages for the loss of reputation” and a permanent injunction against Shekhar Gupta, Mohana Basu, Priyanka Pulla and Saba Naqvi “to cease the publication of articles, tweets, etc. that are palpably defamatory” against Das.

With the lawsuit, Gobardhan Das is now in the company of many other scientists, and in fact authors of research reports in general, around the world who have clashed with journalists over questions about the former’s work and integrity.

Share. Facebook Twitter Pinterest LinkedIn Tumblr Email
Biotech Express
  • Website
  • Facebook
  • Twitter
  • LinkedIn

ISSN: 2454-6968 | Biotech Express Magazine publishes articles in the field of biotechnology and allied sciences in a way that have never been presented earlier. It publishes Editorials, Guest Articles, Reports, Interviews, Current News of Govt. Academics and Business, Research Highlights and Notifications of Events, Jobs, Research Proposals in the field of Biotechnology, Biological Sciences, Life Sciences, Microbiology, Biochemistry, Neurosciences, Genetics, Medical Sciences, BioPharma etc.

Related Posts

Elsevier ranked Prof Ashok Pandey among top 5 scientists of India

The Lancet was made for political activism- For 200 years, it has thrived on melodrama and scandal

Concord Biotech: Stock Market’s New Biotech entrant ready with IPO

Leave A Reply Cancel Reply

Current Issue – October 2023
Upcoming Event

                   VIEW SUBSCRIPTION PLANS

JOBS/NOTIFICATIONS

   

         CLICK HERE FOR RECENT NOTICES

Recent Posts
  • Govt funds dry up to honour Indian scientists October 23, 2023
  • Elsevier ranked Prof Ashok Pandey among top 5 scientists of India October 22, 2023
  • A tribute to Father of Indian Green Revolution Dr M S Swaminathan October 21, 2023
  • The Lancet was made for political activism- For 200 years, it has thrived on melodrama and scandal October 15, 2023
  • Valo Therapeutics Announces Acquisition of Bruker Corporation’s Latest Mass Spectrometer Platform for Tumor Antigen Identification with ValoTx’s PeptiCHIP Technology October 12, 2023
  • FABA and ABF Conduct Hands-on Training on CRISPR-Cas-Mediated Genome Editing in Plants October 12, 2023
  • US FDA grants Orphan Drug Designation for CRO-67 October 10, 2023
  • Integrative Medicines (IM) Market to Grow with a High CAGR during 2023-2035; Increasing Adoption of Natural Remedies Around the World to Drive Market Growth October 5, 2023
  • Scientists create human embryo in lab without eggs, sperm September 23, 2023
  • Concord Biotech: Stock Market’s New Biotech entrant ready with IPO July 31, 2023
  • National Research Foundation (NRF): facing support and resistance from scientific communities! Why? July 25, 2023
  • Biodiversity- preserve or perish July 24, 2023
  • Dr Rajesh Gokhale assumes charge as Secretary of Department of Science and Technology July 23, 2023
  • Advancing allergy detection and management in India: A pathway to improved health July 23, 2023
  • Gujarat govt signs MOUs with 15 companies for ₹2000 cr in a single day July 22, 2023
  • Pune biotech firm announces cheaper drug for colorectal cancer July 21, 2023
  • Ambiq Propels Remote Healthcare Monitoring Sector Growth with New Ultra-Low Processors July 20, 2023
  • BMJ Open retracted a diabetes paper because it was funded by tobacco company July 19, 2023
  • Indian scientist made First Marwari horse foal through Embryo transfer technology July 12, 2023
  • Prof Rajeev Varshney becomes the 4th Indian Agricultural Scientist to be elected as Fellow of the Royal Society May 22, 2023
  • FABA holds Conference on Antimicrobial Resistance Stewardship Series May 22, 2023
  • COVID no longer a global health emergency, WHO says May 18, 2023
  • Chemist in India loses seven papers of biology, blames outsourcing of images May 17, 2023
  • Indian Research scholars express frustration over DST’s tweet, plan stir May 16, 2023
  • BioAsia 2023 to be held in February 24-26 in Telangana, India January 10, 2023
  • Praj Industries and ESIIC partner to further bioeconomy in Egypt November 10, 2022
  • Who is The Real Anthony Fauci? A true Doctor, liar, pharma profiteer or a totalitarian? November 1, 2022
  • Guestorial: MALNUTRITION ACCELERATES THE METABOLIC AGE October 31, 2022
  • Event: Australia’s biggest week in biotech kicks off in Perth October 26, 2022
  • $3 trillion growth reported for biotech sector in USA October 25, 2022
Archives
Categories
  • Articles
  • Articles- Editorials
  • Articles- Guestorials
  • BioControversial
  • BioEvents
  • BioGadgets
  • BioPolicies
  • BioResearch – Academic
  • Biotech News
  • Biotech News – Featured
  • Contents
  • Interviews
  • Interviews – Academia
  • Interviews – Industry
  • SARS- CoV2 & COVID-19 Updates
  • startups
About Us

Biotech Express Magazine publishes articles in the field of biotechnology and allied sciences in a way that have never been presented earlier. It publishes Editorials, Guest Articles, Reports,  Interviews, Current News of Govt. Academics and Business, Research Highlights and Notifications of Events, Jobs, Research Proposals in the field of Biotechnology and allied sciences like Biological Sciences, Life Sciences, Microbiology, Biochemistry, Neurology, Genetics, Medical Sciences, BioPharma etc.

Call us: _91-9311986177

Email – biotechexpressindia@gmail.com

About Us

About Biotech Express

Advisory and Editorial Board

Contact Us

Policy and Guidelines

Submission policies

Peer review policy    

Copyright policy

 

Follow Us
  • Facebook
  • Twitter
We use cookies to help provide and enhance our service and tailor content and ads. By continuing you agree to the use of cookies. Copyright © 2013-2020 Biotech Express except certain content provided by third parties.

Type above and press Enter to search. Press Esc to cancel.